Research News and Research

RSS

Democratic congressional leaders plan to approve Federal embryonic stem cell funding measure in January

Democratic congressional leaders in January 2007 plan to approve a bill similar to a measure (HR 810) President Bush vetoed earlier this year that would have expanded federal funding for human embryonic stem cell research, the AP/Houston Chronicle reports (Kellman, AP/Houston Chronicle, 11/29).

2 Dec 2006

Traditionally low status of girls fueling child sexual abuse in sub-Saharan Africa

The problem of child sexual abuse in sub-Saharan Africa remains "stubbornly resistant to change" in part because of the traditionally low status of girls, a "lingering view" that sexual abuse should be dealt with privately and justice systems that "constitute obstacle courses" for women, some child advocates have said, the New York Times reports.

2 Dec 2006

CleveMed awarded $245,000 NIH grant to develop a device for quantifying the efficacy of alternative medicine techniques

Cleveland Medical Devices has announced that it has been awarded $245,000 in NIH SBIR funding.

2 Dec 2006

Why COX-2 inhibitors such as Vioxx can cause heart attacks and strokes

COX-2 inhibitors are primarily used to treat pain in conditions such as arthritis. They work by blocking the COX-2 enzyme, which is expressed at sites of inflammation and underlies the production of hormones called prostaglandins which swell the joints and cause the feeling of pain.

2 Dec 2006

HIV/AIDS cases in Shanghai increase by 70%, HIV/AIDS discrimination in China continues

The number of reported HIV/AIDS cases in Shanghai, China, in the first 11 months of 2006 increased by 74% compared with the same period in 2005, the city's Municipal Public Health Bureau said on Wednesday, Xinhuanet reports (Xinhuanet, 11/29).

2 Dec 2006

Some institutional review board members have ties to Rx, medical device firms

About 15% of institutional review board members, who are charged with deciding whether proposed clinical trials are ethical and safe, in the past year were asked to judge at least one proposal involving a drug or medical device company in which they have a financial stake or involving one of those company's competitors, according to a survey published in the New England Journal of Medicine

2 Dec 2006

Schizophrenia treatment with older, generic antipsychotics cheaper, as effective as treatment with newer drugs

Treating schizophrenia patients with older, less expensive antipsychotic drugs reduces overall treatment costs by up to 30% and produces no increase in side effects or decrease in effectiveness compared with newer, brand-name medications.

2 Dec 2006

High dopamine transporter levels not linked to attention-deficit hyperactivity disorder

Results from a brain-imaging study conducted at the U.S. Department of Energy's Brookhaven National Laboratory in collaboration with Mount Sinai School of Medicine in New York indicate that levels of a brain protein proposed as a diagnostic marker for attention-deficit hyperactivity disorder (ADHD) are not positively correlated with the disease.

2 Dec 2006